ADC Therapeutics Shares Face Brutal Sell-Off After Disappointing Clinical Trial Results

Sangamo Therapeutics Sees Shares Surge as FDA Grants Fast Track for Landmark Transplant Rejection Therapy

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

Kala Bio's Overnight Leap: Unpacking the Nearly 38% Stock Rocket

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

Cassava Sciences Soars: CEO's Insider Buy Signals Confidence After Federal Clearance

Praxis Precision Medicines Stock Plummets Following Brutal Short-Seller Attack from Culper Research

The Fibromyalgia Frontier: Why Tonix Pharmaceuticals Just Rocketed into the Spotlight

High Stakes & Shifting Sands: Inside Pharma's Latest Power Plays in Cancer and Autoimmune Disease

A Bittersweet Wait: Immuron's Travelan Data Faces an Unexpected Delay

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors

Nuvation Bio Soars: Pioneering Trial Success Ignites "Buy" Rating from Jefferies

Zevra Therapeutics Shares Skyrocket Amid Intense Takeover Speculation

Agios Shares Plummet as FDA Halts Pyrukynd's Thalassemia Review, Sending Shockwaves Through Biotech